Home/Smart Money/Propel Bio Management, LLC
§ 13F · FUND PROFILE

Propel Bio Management, LLC.

AUM · $191M (13F)Positions · 29Turnover · n/a · Q2Filed · Aug 13, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$10M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS

The book · Q2 2026

FILED AUG 13, 2026
#TickerNameShares$ value% portΔ Q2
1PAGPPLAINS GP HOLDINGS LP-CL1.27M$31M16.2%±0%
2ACHVACHIEVE LIFE SCIENCES INC4.03M$26M13.8%+7%
3CORTCORCEPT THERAPEUTICS INC136K$12M6.2%−8%
4PHATPHATHOM PHARMACEUTICALS I1.05M$11M6.0%+25%
5DCTHDELCATH SYSTEMS INC871K$11M5.7%−11%
6MISTMILESTONE PHARMACEUTICALS7.43M$10M5.2%+80%
7CMPSCOMPASS PATHWAYS PLC573K$8M4.2%−23%
8KYTXKYVERNA THERAPEUTICS INC883K$8M4.1%+37%
9ARTVARTIVA BIOTHERAPEUTICS IN696K$7M3.5%+376%
10ABEOABEONA THERAPEUTICS INC983K$6M3.2%−26%
§ 02 · SECTOR ALLOCATION

Where the money is

Sector data pending
§ 03 · THE PROPEL SIGNAL

AC read

Propel Bio Management, LLC is a Other fund managing $191 million in assets. The fund runs a focused portfolio of just 29 positions.

Read the full dossier →